Maura Massimino, Sabina Vennarini, Francesca Romana Buttarelli, Manila Antonelli, Francesca Colombo, Simone Minasi, Emilia Pecori, Paolo Ferroli, Carlo Giussani, Marco Schiariti, Elisabetta Schiavello, Veronica Biassoni, Alessandra Erbetta, Luisa Chiapparini, Olga Nigro, Luna Boschetti, Francesca Gianno, Evelina Miele, Piergiorgio Modena, Loris De Cecco, Bianca Pollo, Francesco Barretta
BACKGROUND: First-line therapies for medulloblastoma(MBL) are obtaining higher survival-rates while decreasing late-effects, but treatment at relapse is not standardized. We report here the experience with MBL re-irradiation(re-RT), its timing and outcome in different clinical settings and tumor groups. METHODS: Patient's staging/treatment at diagnosis, histotypes/molecular subgroups, relapse site/s, re-treatments outcome are reported. RESULTS: 25 patients were included, with a median age of 11...
July 2023: Journal of Neuro-oncology